Sex-aware Cross-tissue Regulatory Transformer Identified Sexually Dimorphic Alzheimer's Disease Risk Loci and Causal Cellular Circuit
Cheng, Z.; Judaprawira, S.; Perez, J.; Goldstein, A.. medRxiv (preprint), 2026-09-09
Topic: Brain proteins, microglia and lab models
Plain-language summary
Sex differences in Alzheimers disease (AD) genetic effects and regulatory contexts remain incompletely resolved. We analyzed 449,335 European-ancestry participants using sex-stratified and genotype-by-sex models and developed STAGE-AD, a Transformer integrating molecular QTLs, epigenomic and single-cell annotations. Sex-stratified analyses identified eight female and three male genome-wide-significant signals provisionally classified as novel. Primary test-set area under the precision-recall curve was 0.895 (95% confidence interval, 0.877-0.912), decreasing to 0.751 under locus hold-out and 0.681 under APOE-region hold-out. Statistical-genetic integration in independent HUNT and MVP cohorts supported 236 genes at 106 loci. Prespecified lifetime-risk assumptions yielded liability-scale SNP heritabilities of 11.42% in females and 9.23% in males. Ablations indicated that female-biased predictions depended on glial annotations and male-biased predictions on endothelial and oligodendrocyte annotations. Eleven candidate variant-gene-tissue-cell-pathology chains were evaluated using multi-omics and neuropathological data from 579 NPAD brain donors. These findings underscore the importance of considering sex-specific genetic architectures in the study of health conditions, including Alzheimers disease, paving the way for more targeted treatment strategies.
What this study adds
Evidence grade: Low
The record lists 449,335 participants. This study identified sex-specific genetic signals and cellular pathways related to Alzheimer's disease risk. Reported effect size: 11.42%; 9.23%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cheng, Z., Judaprawira, S., Perez, J., & Goldstein, A. (2026). Sex-aware Cross-tissue Regulatory Transformer Identified Sexually Dimorphic Alzheimer's Disease Risk Loci and Causal Cellular Circuit. medRxiv (preprint). https://doi.org/10.64898/2026.09.08.26362488
Vancouver
Cheng Z, Judaprawira S, Perez J, Goldstein A. Sex-aware Cross-tissue Regulatory Transformer Identified Sexually Dimorphic Alzheimer's Disease Risk Loci and Causal Cellular Circuit. medRxiv (preprint). 2026. doi:10.64898/2026.09.08.26362488.
BibTeX
@article{cheng2026-ba023161,
author = {Cheng, Z. and Judaprawira, S. and Perez, J. and Goldstein, A.},
title = {{Sex-aware Cross-tissue Regulatory Transformer Identified Sexually Dimorphic Alzheimer's Disease Risk Loci and Causal Cellular Circuit}},
journal = {medRxiv (preprint)},
year = {2026},
doi = {10.64898/2026.09.08.26362488},
url = {https://doi.org/10.64898/2026.09.08.26362488}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Sex-stratified analyses identified eight female and three male genome-wide-significant signals provisionally classified as novel.
- Ablations indicated that female-biased predictions depended on glial annotations and male-biased predictions on endothelial and oligodendrocyte annotations.
- These findings underscore the importance of considering sex-specific genetic architectures in the study of health conditions, including Alzheimers disease, paving the way for more targeted treatment strategies.
Why it matters
This study identified sex-specific genetic signals and cellular pathways related to Alzheimer's disease risk. It suggests that sex-specific genetic architectures should be considered for future targeted treatment strategies, but no treatment, cure, or prevention was tested.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Participants449,335
- Effect size11.42%; 9.23%
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 31 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on impact for its field and year and senior author's track record, so those were left out: it earned 28 of the 90 points we could judge it on, which is 31 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv (preprint)) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 4 / 4 | 449,335 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Adam Goldstein holds only 2 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 2 / 3 | Cornell University: institution h-index 1,649 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 28 / 90 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 28 of the 90 points we could judge it on is 31 out of 100. |
| Total | 31 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.